Envista Holdings Corporation Common stock, $0.01 par value per share (NVST)

Price$23.37

Value ScoreB

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)7.30%

Price vs S&P 500 (4W)-15.53%

VGM Score61.35

Market Capitalization$3.83B

P/E Ratio (Annual)81.54x

All Metrics

P/CF (Annual)13.90x

Book Value / Share (Quarterly)$18.90

P/TBV (Annual)1.44x

Revenue Growth (3Y)1.91%

Cash Flow / Share (Quarterly)$1.35

Price vs S&P 500 (YTD)-2.46%

Gross Margin (TTM)55.25%

Net Profit Margin (TTM)2.41%

EPS (TTM)$0.40

10-Day Avg Trading Volume4.29M

EPS Excl Extra (TTM)$0.40

Revenue Growth (5Y)7.11%

EPS (Annual)$0.28

ROI (Annual)1.03%

Gross Margin (Annual)55.02%

Net Profit Margin (5Y Avg)-4.74%

Cash / Share (Quarterly)$6.65

P/E Basic Excl Extra (TTM)56.61x

Revenue Growth QoQ (YoY)14.36%

EPS Growth (5Y)6.49%

P/E Normalized (Annual)81.54x

ROA (Last FY)0.83%

Revenue Growth TTM (YoY)12.15%

EBITD / Share (TTM)$1.68

ROE (5Y Avg)-4.97%

Operating Margin (TTM)8.53%

Cash Flow / Share (Annual)$1.41

P/B Ratio1.24x

P/B Ratio (Quarterly)1.37x

Net Income / Employee (Annual)$3,900

EV / Revenue (TTM)1.49x

Net Interest Coverage (TTM)5.84x

ROA (TTM)1.20%

EPS Growth QoQ (YoY)124.30%

EV / EBITDA (TTM)14.91x

EPS Incl Extra (Annual)$0.28

Current Ratio (Annual)2.38x

Quick Ratio (Quarterly)1.93x

3-Month Avg Trading Volume3.10M

52-Week Price Return27.57%

EV / Free Cash Flow (Annual)18.18x

P/E Incl Extra (TTM)56.61x

Revenue / Employee (TTM)$234,000

Tangible BV / Share (Quarterly)$15.02

P/S Ratio (Annual)1.41x

Asset Turnover (Annual)0.48x

52-Week High$30.42

Operating Margin (5Y Avg)-1.51%

EPS Excl Extra (Annual)$0.28

CapEx CAGR (5Y)-1.03%

Tangible BV CAGR (5Y)0.14%

26-Week Price Return23.23%

Quick Ratio (Annual)1.93x

13-Week Price Return-19.62%

Total Debt / Equity (Annual)0.47x

Current Ratio (Quarterly)2.44x

Enterprise Value$4.19B

Revenue / Share Growth (5Y)6.46%

Asset Turnover (TTM)0.50x

Book Value / Share Growth (5Y)-4.00%

Revenue / Employee (Annual)$226,600

Inventory Turnover (Annual)4.62x

Pretax Margin (Annual)6.52%

Cash / Share (Annual)$7.40

3-Month Return Std Dev38.56%

Gross Margin (5Y Avg)56.72%

Net Income / Employee (TTM)$5,600

EBITDA CAGR (5Y)24.43%

EBITDA Interim CAGR (5Y)-7.11%

ROE (Last FY)1.51%

Net Interest Coverage (Annual)6.46x

EPS Basic Excl Extra (Annual)$0.28

P/FCF (TTM)16.24x

Receivables Turnover (TTM)6.77x

EV / Free Cash Flow (TTM)19.02x

Total Debt / Equity (Quarterly)0.47x

EPS Incl Extra (TTM)$0.40

Receivables Turnover (Annual)6.86x

ROI (TTM)1.49%

P/S Ratio (TTM)1.36x

Pretax Margin (5Y Avg)-3.53%

Revenue / Share (Annual)$16.07

Tangible BV / Share (Annual)$15.13

Forward P/E16.28x

Free OCF CAGR (5Y)-0.50%

Price vs S&P 500 (52W)-0.63%

P/E Ratio (TTM)56.61x

Year-to-Date Return8.48%

5-Day Price Return0.51%

EPS Normalized (Annual)$0.28

ROA (5Y Avg)-2.55%

Net Profit Margin (Annual)1.73%

Month-to-Date Return-9.21%

Cash Flow / Share (TTM)$1.87

EBITD / Share (Annual)$1.51

EPS Growth (3Y)-41.23%

Operating Margin (Annual)7.95%

LT Debt / Equity (Annual)0.47x

P/CF (TTM)14.08x

ROI (5Y Avg)-3.18%

P/E Excl Extra (TTM)56.61x

LT Debt / Equity (Quarterly)0.47x

EPS Basic Excl Extra (TTM)$0.40

P/TBV (Quarterly)1.73x

P/B Ratio (Annual)1.15x

Inventory Turnover (TTM)4.47x

Pretax Margin (TTM)7.14%

Book Value / Share (Annual)$18.96

Price vs S&P 500 (13W)-29.37%

Net Margin Growth (5Y)0.00%

Beta0.89x

P/FCF (Annual)16.63x

Revenue / Share (TTM)$16.88

ROE (TTM)2.18%

52-Week Low$17.78

vGradeB

gGradeB

mGradeC

vgmGradeB

Show chart for

Earnings Surprise History

Q1 260.36est. 0.32

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.71

3.90

3.95

3.90

Industry Peers(1)

Symbol	Value Score	Growth Score	Momentum Score	Price
NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share	B	B	C	$23.37
XRAYDENTSPLY SIRONA Inc.	B	F	C	$10.02

About

Envista Holdings Corp develops and manufactures dental implants, orthodontic systems, consumables, and equipment for dental professionals globally. The company's Specialty Products & Technologies segment drives revenue through implant systems, regenerative solutions, prosthetics, and orthodontic products, while its Equipment & Consumables segment serves broader clinical needs. North America is the company's primary market, with significant exposure to Western Europe and emerging markets.